鼻咽癌放射線治療、頭頸癌放射治療、胃癌放射治療、胰臟癌放射治療、肝癌放射治療、食道癌放射治療、姑息性放射治療
Radiotherapy for nasopharyngeal carcinoma, head and neck cancer, Gastric cancer, Pancreatic cancer, Hepatocellular carcinoa and Esophageal cancer.
Palliative radiotherapy for symptomatic relief.

癌症治療、威力刀、螺旋刀、電腦刀、影像導航放射治療、迅弧放射治療技術

台中榮民總醫院 放射腫瘤部 住院醫師
台中榮民總醫院 放射腫瘤部 總醫師
台中榮民總醫院 放射腫瘤部 主治醫師

長庚大學中西醫學系雙主修

放射腫瘤專科醫師

中國醫藥大學 中西醫結合研究所 博士班 進修中

鼻咽癌基因研究、頭頸癌長期副作用監測及評估。

泛醇(Q10)對接受放化療的頭頸部鱗狀細胞癌患者的抗氧化和抗發炎作用。

1. Chiung-Chen Fang, He-Yuan Hsieh, Wen-Cheng Chen, Miao-Fen Chen, Chia-Hsuan Lai, Yu-Yen Chen, Yao-Te Tsai, Shu-Ling Tzeng. Postoperative radiotherapy alone is as effective as postoperative chemoradiotherapy in patients with pT4aN0 gingival cancer with negative surgical margins. Clin Transl Radiat Oncol 2023;41:100641.
2. Hsieh HY, Lu CH, Wang L. Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage "bulky" cervical cancer and survival impact of histological subtype. J Formos Med Assoc 2023;122(3):221-229.

1. Chiung-Chen Fang, He-Yuan Hsieh, Wen-Cheng Chen, Miao-Fen Chen, Chia-Hsuan Lai, Yu-Yen Chen, Yao-Te Tsai, Shu-Ling Tzeng. Postoperative radiotherapy alone is as effective as postoperative chemoradiotherapy in patients with pT4aN0 gingival cancer with negative surgical margins. Clin Transl Radiat Oncol 2023;41:100641.
2. Hsieh HY, Lu CH, Wang L. Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage "bulky" cervical cancer and survival impact of histological subtype. J Formos Med Assoc 2023;122(3):221-229.
3. Hsieh HY, Huang JW, Lu CH, Lin JC, Wang L. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy. J Formos Med Assoc 2019;118(1 Pt 1):99-108. (SCI)
4. Hsieh HY, Hsu CP, Yeh HL, Chuang CY, Lin JF, Chang CF. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma. Kaohsiung J Med Sci 2018;34(5):281-289. (SCI)
5. Hsieh HY, Wang L, Lu CH, Lin JC, Chen CC. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients. J Formos Med Assoc 2018;117(7):613-620. (SCI)
6. Hsieh HY, Yeh HL, Hsu CP, Lin JC, Chuang CY, Lin JF, Chang CF. Feasibility of intensity-modulated radiotherapy for esophageal cancer in definite chemoradiotherapy. J Chin Med Assoc 2016;79(7):375-381. (SCI)